A guide to diagnosing and treating benign prostatic hypertrophy

Area of Science:

• Urology
• Geriatrics
• Public Health

Background:

• Benign prostatic hypertrophy (BPH) is a non-cancerous enlargement of the prostate gland.
• It is a common condition associated with aging, affecting a significant portion of the male population.
• Global incidence of BPH has increased by 70% from 2000-2019, highlighting its growing public health impact.

Purpose of the Study:

• To outline the causes and consequences of benign prostatic hypertrophy.
• To review the available treatment options for BPH.
• To provide comprehensive information for healthcare providers and patients regarding BPH management.

Main Methods:

• This article is a review of existing literature and clinical knowledge on BPH.
• It synthesizes information on the pathophysiology, clinical presentation, and management strategies for BPH.
• No new clinical data was generated; the focus is on summarizing current understanding.

Main Results:

• BPH is a progressive condition linked to aging.
• Untreated BPH can lead to severe complications including acute urinary retention, recurrent urinary tract infections, bladder stones, kidney damage, and hematuria.
• Various treatment options exist, ranging from watchful waiting to medical and surgical interventions.

Conclusions:

• Benign prostatic hypertrophy is a prevalent condition with significant potential for morbidity if unmanaged.
• Early recognition of symptoms and appropriate treatment are crucial to prevent serious health consequences.
• Understanding the causes, consequences, and treatment landscape of BPH is essential for effective patient care.